Media Summary: In the last few years, the pharmaceutical industry Chair, Jinsy A. Andrews, MD, MSc, FAAN, discusses amyotrophic lateral sclerosis in this CME activity titled “A Visual Exploration ... One area within Complex Biologics experiencing tremendous growth

How Does It Work Oligonucleotide Therapies - Detailed Analysis & Overview

In the last few years, the pharmaceutical industry Chair, Jinsy A. Andrews, MD, MSc, FAAN, discusses amyotrophic lateral sclerosis in this CME activity titled “A Visual Exploration ... One area within Complex Biologics experiencing tremendous growth Frank Rigo, PhD, Isis Pharmaceuticals, discusses Exon Skipping. Discover the groundbreaking potential of antisense Muthiah Manoharan, PhD, Alnylam Pharmaceuticals discusses the chemistry of Therapeutic Oligionucleotides.

Mano Manoharan, PhD, Alnylam Pharmaceuticals. PUBLISHED 05/01/2019 In this episode Dr. Steve Perrin, CEO at the ALS Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals Anne Smith, PhD,

Photo Gallery

How Does It Work? | Oligonucleotide Therapies
What are oligonucleotide therapeutics, and how do they work?
How Does It Work? | Antisense Oligonucleotide Therapy
A Visual Exploration of Antisense Oligonucleotide Therapies in ALS
Big Concepts in Brief: What are Oligonucleotides?
Oligonucleotide therapeutic development: Pre-clinical and translational considerations
Antisense oligonucleotide therapy
Scientific Symposium 303  Preclinical and Clinical Development of Oligonucleotide Therapies   Organi
Can Antisense Oligonucleotides REALLY Cure Genetic Disorders?
HOT TOPICS | Gene Expression | Modulating with Oligonucleotide-based Therapies
Chemistry of Therapeutic Oligonucleotides: A Brief Overview
Track 4: Making Sense of Antisense and Other Oligonucleotide Therapies
View Detailed Profile
How Does It Work? | Oligonucleotide Therapies

How Does It Work? | Oligonucleotide Therapies

For this week's episode of our “

What are oligonucleotide therapeutics, and how do they work?

What are oligonucleotide therapeutics, and how do they work?

In the last few years, the pharmaceutical industry

How Does It Work? | Antisense Oligonucleotide Therapy

How Does It Work? | Antisense Oligonucleotide Therapy

In this week's installment of our “

A Visual Exploration of Antisense Oligonucleotide Therapies in ALS

A Visual Exploration of Antisense Oligonucleotide Therapies in ALS

Chair, Jinsy A. Andrews, MD, MSc, FAAN, discusses amyotrophic lateral sclerosis in this CME activity titled “A Visual Exploration ...

Big Concepts in Brief: What are Oligonucleotides?

Big Concepts in Brief: What are Oligonucleotides?

What

Oligonucleotide therapeutic development: Pre-clinical and translational considerations

Oligonucleotide therapeutic development: Pre-clinical and translational considerations

One area within Complex Biologics experiencing tremendous growth

Antisense oligonucleotide therapy

Antisense oligonucleotide therapy

Frank Rigo, PhD, Isis Pharmaceuticals, discusses Exon Skipping.

Scientific Symposium 303  Preclinical and Clinical Development of Oligonucleotide Therapies   Organi

Scientific Symposium 303 Preclinical and Clinical Development of Oligonucleotide Therapies Organi

...

Can Antisense Oligonucleotides REALLY Cure Genetic Disorders?

Can Antisense Oligonucleotides REALLY Cure Genetic Disorders?

Discover the groundbreaking potential of antisense

HOT TOPICS | Gene Expression | Modulating with Oligonucleotide-based Therapies

HOT TOPICS | Gene Expression | Modulating with Oligonucleotide-based Therapies

Oligonucleotide

Chemistry of Therapeutic Oligonucleotides: A Brief Overview

Chemistry of Therapeutic Oligonucleotides: A Brief Overview

Muthiah Manoharan, PhD, Alnylam Pharmaceuticals discusses the chemistry of Therapeutic Oligionucleotides.

Track 4: Making Sense of Antisense and Other Oligonucleotide Therapies

Track 4: Making Sense of Antisense and Other Oligonucleotide Therapies

... further delay I

Chemistry of Oligonucleotide Therapeutics 101

Chemistry of Oligonucleotide Therapeutics 101

Mano Manoharan, PhD, Alnylam Pharmaceuticals.

What are Antisense oligonucleotides?

What are Antisense oligonucleotides?

PUBLISHED 05/01/2019 In this episode Dr. Steve Perrin, CEO at the ALS

How Does It Work? | Peptide-Oligonucleotide Conjugates

How Does It Work? | Peptide-Oligonucleotide Conjugates

This week's episode of our “

Oligonucleotide therapeutic development: Clinical pharmacology considerations

Oligonucleotide therapeutic development: Clinical pharmacology considerations

One area within Complex Biologics experiencing tremendous growth

Oligonucleotides as a New Therapeutic Class:  Progress Report & Prescription

Oligonucleotides as a New Therapeutic Class: Progress Report & Prescription

Paul Burke, PhD, Burke Bioventures LLC.

Adrian R.  Krainer - Antisense Oligonucleotides for Rare-Disease Therapy

Adrian R. Krainer - Antisense Oligonucleotides for Rare-Disease Therapy

Adrian Krainer

Global Genes LIVE! Are Oligonucleotides Therapeutics

Global Genes LIVE! Are Oligonucleotides Therapeutics

... me and talk about

Antisense Oligonucleotides for Prion Disease

Antisense Oligonucleotides for Prion Disease

Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals Anne Smith, PhD,